Details for 2015820351
Up to date per 02.04.2026
Actions
Details for 2015820351
Deleted
European Patent
11.10.2017 A
26.05.2021 B1
05.12.2014
EP
14196605
A61K 9/20 20060101AFI20200414BHEP
Owner
Aragon Pharmaceuticals, Inc.10990 Wilshire Blvd, Suite 400 Los Angeles, CA 90024US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
VERRECK, Geertc/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE